The Administration’s Orwellian Defense of Importing Foreign Price Controls

The Trump administration is out with a new blog post defending its plan to adopt foreign price controls for medicines covered under Medicare Part B. The blog was written in the wake of growing backlash from free-market thought leaders who are challenging the administration’s draconian proposal.
The latest blog post from the Department of Health and Human Services (HHS) includes numerous inaccuracies, with the chief example being the distorted view of how drugmakers set their prices in